Alaina M. Davis

Alaina M. Davis

Auto-generated profile, based on publicly available information

Alaina M. Davis

A. Davis, MD, MPH, Department of Pediatrics, Division of Pediatric Rheumatology, Monroe Carell Junior Children's Hospital at Vanderbilt, Nashville, Tennessee, USA;

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2018 in Lupus
Verified
Journal Article
Closed access
PDF file
ADA M Davis
A M Davis
TGT B Graham
T B Graham
YZY Zhu
Y Zhu
MMM L McPheeters
M L McPheeters
Depression and medication nonadherence are important in managing chronic diseases, but little is known about these factors in childhood-onset systemic lupus erythematosus (cSLE). The objectives of this cross-sectional study were to estimate prevalence of depression and medication nonadherence, describe demographic and disease characteristics associated with depression and medication nonadherence, and evaluate the association between depression and medication nonadherence in cSLE patients. Patients with cSLE (n = 51) completed validated screening questionnaires to identify depression and medication nonadherence, Patient Health Questionnaire-9 and Medication Adherence Self-Report Inventory, respectively. Demographic and disease characteristics were obtained via chart abstraction, and compared between groups of depression or medication nonadherence status. A multivariable linear regression model adjusting for propensity scores was conducted to evaluate the association between depression and medication nonadherence. The prevalence of a positive depression screen was 58.8%, and seven patients reported suicidal ideation (13.7%). The prevalence of self-reported medication nonadherence was 19.7%. No statistically significant differences for demographic and disease characteristics were found between patients with a positive vs. negative depression screen. Patients reporting medication nonadherence were more likely to have longer disease duration (4.8 vs. 2.6 years, p = 0.035). As the severity of depression symptoms increased, the degree of medication nonadherence also increased (beta = –1.89; p = 0.011). The prevalence of depression and medication nonadherence is high in cSLE, and these factors have a direct relationship. Interventions that better recognize and treat depression and increase rates of medication adherence are needed to improve outcomes in cSLE.

28 December 2017 in Pediatric Rheumatology
Verified
Journal Article
Open access
PDF file
ADAlaina M. Davis
Alaina M. Davis
TRTamar B. Rubinstein
Tamar B. Rubinstein
MRMartha Rodriguez
Martha Rodriguez
AKAndrea M. Knight
Andrea M. Knight
Youth with rheumatologic diseases have a high prevalence of comorbid mental health disorders. Individuals with comorbid mental health disorders are at increased risk for adverse outcomes related to mental health as well as their underlying rheumatologic disease. Early identification and treatment of mental health disorders has been shown to improve outcomes, but current systems of care fall short in providing adequate mental health services to those in need. Pediatric rheumatologists are uniquely positioned to provide mental health screening and intervention for youth with rheumatologic diseases due to the frequency of patient encounters and ongoing therapeutic relationship with patients and families. However, additional training is likely required for pediatric rheumatologists to provide effective mental health care, and focusing efforts on providing trainees with mental health education is key to building competency. Potential opportunities for improved mental health education include development of clinical guidelines regarding mental health screening and management within pediatric rheumatology settings and incorporation of mental health didactics, workshops, and interdisciplinary clinic experiences into pediatric rheumatology fellowship curricula. Additional steps include mental health education for patients and families and focus on system change, targeting integration of medical and mental health care. Research is needed to better define the scope of the problem, determine effective strategies for equipping pediatric rheumatologists with skills in mental health intervention, and develop and implement sustainable systems for delivery of optimal mental health care to youth with rheumatologic diseases.

28 June 2018 in Arthritis Care & Research
Verified
Journal Article
Closed access
PDF file
AKAndrea Knight
Andrea Knight
MVMichelle Vickery
Michelle Vickery
LFLauren Faust
Lauren Faust
EMEyal Muscal
Eyal Muscal
ADAlaina Davis
Alaina Davis
TIthe Childhood Arthritis and Rheumatology Research Alliance Investigators
the Childhood Arthritis and Rheumatology Research Alliance Investigators

21 November 2021 in Arthritis Care & Research
Verified
Journal Article
Closed access
PDF file
TRTamar B. Rubinstein
Tamar B. Rubinstein
MDMarija Dionizovik‐Dimanovski
Marija Dionizovik‐Dimanovski
ADAlaina M. Davis
Alaina M. Davis
CSChelsey Smith
Chelsey Smith
LFLauren Faust
Lauren Faust
FWfor the CARRA Mental Health Workgroup
for the CARRA Mental Health Workgroup

3 December 2014 in Maternal and Child Health Journal
Verified
Journal Article
Closed access
PDF file
ADAlaina M. Davis
Alaina M. Davis
SMSara E. McFadden
Sara E. McFadden
BPBarron L. Patterson
Barron L. Patterson
SBShari L. Barkin
Shari L. Barkin

15 September 2022 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
ADAlaina Davis
Alaina Davis
JFJennifer Faerber
Jennifer Faerber
KAKaveh Ardalan
Kaveh Ardalan
HKHannah Katcoff
Hannah Katcoff
MKMarisa Klein-Gitelman
Marisa Klein-Gitelman
AKAndrea Knight
Andrea Knight
Objective: To examine the effect of psychiatric diagnoses on healthcare use in youth with systemic lupus erythematosus (SLE) during their first year of SLE care.Methods: We conducted a retrospective cohort study using claims from 2000 to 2013 from Clinformatics Data Mart (OptumInsight). Youth aged 10 years to 24 years with an incident diagnosis of SLE (≥ 3 International Classification of Diseases, 9th revision, codes for SLE 710.0, > 30 days apart) were categorized as having: (1) a preceding psychiatric diagnosis in the year before SLE diagnosis, (2) an incident psychiatric diagnosis in the year after SLE diagnosis, or (3) no psychiatric diagnosis. We compared ambulatory, emergency, and inpatient visits in the year after SLE diagnosis, stratified by nonpsychiatric and psychiatric visits. We examined the effect of childhood-onset vs adult-onset SLE by testing for an interaction between age and psychiatric exposure on outcome.Results: We identified 650 youth with an incident diagnosis of SLE, of which 122 (19%) had a preceding psychiatric diagnosis and 105 (16%) had an incident psychiatric diagnosis. Compared with those without a psychiatric diagnosis, youth with SLE and a preceding or incident psychiatric diagnosis had more healthcare use across both ambulatory and emergency settings for both nonpsychiatric and psychiatric-related care. These associations were minimally affected by age at time of SLE diagnosis.Conclusion: Psychiatric comorbidity is common among youth with newly diagnosed SLE and is associated with greater healthcare use. Interventions to address preceding and incident psychiatric comorbidity may decrease healthcare burden for youth with SLE.